Capital City Trust Company Cut Its Altria Group (MO) Holding as Stock Declined; As Metlife (MET) Valuation Declined, Shareholder Sit Investment Associates Trimmed Stake by $9.62 Million

December 16, 2017 - By Hazel Jackson

Capital City Trust Company decreased its stake in Altria Group Inc (MO) by 54.45% based on its latest 2017Q2 regulatory filing with the SEC. Capital City Trust Company sold 7,000 shares as the company’s stock declined 2.84% while stock markets rallied. The institutional investor held 5,855 shares of the farming and seeds and milling company at the end of 2017Q2, valued at $436,000, down from 12,855 at the end of the previous reported quarter. Capital City Trust Company who had been investing in Altria Group Inc for a number of months, seems to be less bullish one the $136.76B market cap company. The stock decreased 0.17% or $0.12 during the last trading session, reaching $71.67. About 14.17M shares traded or 102.57% up from the average. Altria Group, Inc. (NYSE:MO) has risen 11.92% since December 16, 2016 and is uptrending. It has underperformed by 4.78% the S&P500.

Sit Investment Associates Inc decreased its stake in Metlife Inc (MET) by 41.83% based on its latest 2017Q2 regulatory filing with the SEC. Sit Investment Associates Inc sold 178,211 shares as the company’s stock declined 4.70% while stock markets rallied. The institutional investor held 247,814 shares of the finance company at the end of 2017Q2, valued at $13.62 million, down from 426,025 at the end of the previous reported quarter. Sit Investment Associates Inc who had been investing in Metlife Inc for a number of months, seems to be less bullish one the $54.10 billion market cap company. The stock decreased 2.06% or $1.08 during the last trading session, reaching $51.41. About 15.46 million shares traded or 274.60% up from the average. MetLife, Inc. (NYSE:MET) has risen 13.92% since December 16, 2016 and is uptrending. It has underperformed by 2.78% the S&P500.

Among 19 analysts covering Altria Group Inc. (NYSE:MO), 13 have Buy rating, 0 Sell and 6 Hold. Therefore 68% are positive. Altria Group Inc. had 51 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Equal-Weight” rating on Tuesday, November 29 by Morgan Stanley. The firm earned “Buy” rating on Monday, June 27 by Stifel Nicolaus. On Thursday, July 30 the stock rating was downgraded by Credit Agricole to “Outperform”. Jefferies maintained it with “Hold” rating and $67.0 target in Thursday, August 24 report. Citigroup initiated it with “Buy” rating and $72 target in Tuesday, September 13 report. The stock of Altria Group, Inc. (NYSE:MO) has “Underperform” rating given on Thursday, March 23 by RBC Capital Markets. Argus Research upgraded the shares of MO in report on Monday, May 9 to “Buy” rating. The stock of Altria Group, Inc. (NYSE:MO) has “Buy” rating given on Thursday, October 26 by Cowen & Co. As per Tuesday, November 3, the company rating was downgraded by RBC Capital Markets. The company was upgraded on Wednesday, January 4 by Bank of America.

Since August 10, 2017, it had 0 insider purchases, and 2 selling transactions for $2.95 million activity. DEVITRE DINYAR S also sold $1.96 million worth of Altria Group, Inc. (NYSE:MO) shares.

Investors sentiment increased to 0.91 in 2017 Q2. Its up 0.01, from 0.9 in 2017Q1. It improved, as 63 investors sold MO shares while 529 reduced holdings. 97 funds opened positions while 444 raised stakes. 1.16 billion shares or 0.78% less from 1.17 billion shares in 2017Q1 were reported. Tarbox Family Office holds 6,482 shares or 0.24% of its portfolio. Grassi Investment Mgmt reported 1.64% of its portfolio in Altria Group, Inc. (NYSE:MO). Stifel reported 845,526 shares. Personal Capital Advisors Corporation owns 6,922 shares. Perkins Coie Trust Company holds 410 shares. At Bankshares accumulated 0.09% or 10,545 shares. Bainco International Invsts owns 5,864 shares for 0.07% of their portfolio. Annex Advisory Svcs Llc stated it has 0.07% in Altria Group, Inc. (NYSE:MO). Huntington Bank & Trust accumulated 366,410 shares. Boys Arnold & accumulated 30,597 shares. Credit Agricole S A invested in 1.93 million shares or 0.47% of the stock. The Wisconsin-based Morgan Dempsey Lc has invested 2.85% in Altria Group, Inc. (NYSE:MO). Windsor Cap Management Ltd Liability Company owns 12,366 shares for 0.46% of their portfolio. Exxonmobil Investment Mngmt Tx stated it has 0.69% in Altria Group, Inc. (NYSE:MO). Advisory Svcs Network Ltd Co, a Georgia-based fund reported 53,537 shares.

Analysts await Altria Group, Inc. (NYSE:MO) to report earnings on February, 7. They expect $0.81 earnings per share, up 19.12% or $0.13 from last year’s $0.68 per share. MO’s profit will be $1.55 billion for 22.12 P/E if the $0.81 EPS becomes a reality. After $0.90 actual earnings per share reported by Altria Group, Inc. for the previous quarter, Wall Street now forecasts -10.00% negative EPS growth.

Investors sentiment decreased to 0.94 in 2017 Q2. Its down 0.06, from 1 in 2017Q1. It dived, as 65 investors sold MET shares while 349 reduced holdings. 81 funds opened positions while 307 raised stakes. 772.09 million shares or 1.67% less from 785.23 million shares in 2017Q1 were reported. Sit Associate owns 247,814 shares. Gulf Savings Bank (Uk), United Kingdom-based fund reported 290,267 shares. 5,720 were reported by Cls Invs Ltd Liability. Kanawha Capital Mgmt Ltd reported 0.47% stake. Rmb Cap Mgmt Limited holds 32,894 shares or 0.05% of its portfolio. California-based Aperio Gru Limited Liability Com has invested 0.16% in MetLife, Inc. (NYSE:MET). Ent Fincl holds 0.03% in MetLife, Inc. (NYSE:MET) or 1,073 shares. Amalgamated Bancorp stated it has 105,686 shares or 0.19% of all its holdings. Evercore Wealth Mngmt Ltd Llc has invested 0.02% in MetLife, Inc. (NYSE:MET). Spears Abacus Advsr Ltd reported 441,032 shares stake. Rnc Llc has invested 1.82% in MetLife, Inc. (NYSE:MET). Regions Financial Corp, a Alabama-based fund reported 693,147 shares. Gradient Limited Liability Company has invested 0.48% in MetLife, Inc. (NYSE:MET). Eastern Bancorporation stated it has 58,140 shares or 0.24% of all its holdings. American Asset Management stated it has 6,119 shares.

Analysts await MetLife, Inc. (NYSE:MET) to report earnings on February, 7. They expect $1.12 EPS, down 17.04% or $0.23 from last year’s $1.35 per share. MET’s profit will be $1.18B for 11.48 P/E if the $1.12 EPS becomes a reality. After $1.09 actual EPS reported by MetLife, Inc. for the previous quarter, Wall Street now forecasts 2.75% EPS growth.

Among 15 analysts covering MetLife (NYSE:MET), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. MetLife had 45 analyst reports since July 31, 2015 according to SRatingsIntel. Wells Fargo maintained the stock with “Buy” rating in Friday, May 5 report. The rating was maintained by RBC Capital Markets on Tuesday, September 5 with “Buy”. Morgan Stanley downgraded MetLife, Inc. (NYSE:MET) on Wednesday, November 11 to “Equal-Weight” rating. The firm has “Mkt Perform” rating given on Monday, November 28 by FBR Capital. RBC Capital Markets maintained MetLife, Inc. (NYSE:MET) rating on Tuesday, January 19. RBC Capital Markets has “Outperform” rating and $65.0 target. The firm earned “Neutral” rating on Tuesday, January 5 by Citigroup. The company was downgraded on Tuesday, October 10 by FBR Capital. On Thursday, May 25 the stock rating was upgraded by FBR Capital to “Outperform”. The company was maintained on Monday, August 28 by Credit Suisse. The company was maintained on Monday, August 29 by FBR Capital.

Sit Investment Associates Inc, which manages about $6.54B and $4.04 billion US Long portfolio, upped its stake in Dr Pepper Snapple Group Inc (NYSE:DPS) by 187,950 shares to 197,550 shares, valued at $18.00 million in 2017Q2, according to the filing. It also increased its holding in Physicians Realty Trust (NYSE:DOC) by 281,920 shares in the quarter, for a total of 1.40M shares, and has risen its stake in Dexcom Inc (NASDAQ:DXCM).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: